Results of Recent Large Cholesterol-Lowering Trials and Implications for Clinical Management

This publication has 16 references indexed in Scilit:

• The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts
  New England Journal of Medicine, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease
  Current Opinion in Lipidology, 1995
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Range of serum cholesterol values in the population developing coronary artery disease
  The American Journal of Cardiology, 1995
• Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1995
• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
  Annual Review of Medicine, 1993
• Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.
  Circulation, 1977
• MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE
  The Lancet, 1977